Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza Vaccine
Clinical trial NCT00999206 · COMPLETED
Trial details
- NCT number
- NCT00999206
- Sponsor
- Abbott Biologicals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-08-01
- Enrollment
- 3138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.